![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | April | 7 | 2021 | | 12:00 PM to 1:00 PM US Eastern Time | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) |
|
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | Validating a multiplex immunofluorescence workflow to improve stratification of high-risk, early-stage melanoma samples | | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) |
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) |
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | In this webinar, viewers will: | | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEiN7qqTbXXAMF_A5bxxonRa-I3fulTHkeb8KqjwwWt6UOaaor-y8YdlPFWu8WvAMxVa5ZyL5HCP3pIt9hI2OQVDdd0nC3QYsh6pma9YGfy1e1SWFwLzGx0QJheEky1STlTRPTfAnh0fhq9RfjDDefSVqpbsFeaLSF0M5G4JUJ7veg=s0-d-e1-ft) | Learn about the benefits and limitations of quantitative multiplex immunofluorescence (qmIF) technology |
|
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEiN7qqTbXXAMF_A5bxxonRa-I3fulTHkeb8KqjwwWt6UOaaor-y8YdlPFWu8WvAMxVa5ZyL5HCP3pIt9hI2OQVDdd0nC3QYsh6pma9YGfy1e1SWFwLzGx0QJheEky1STlTRPTfAnh0fhq9RfjDDefSVqpbsFeaLSF0M5G4JUJ7veg=s0-d-e1-ft) | Find out how qmIF is used to stage patients with melanoma |
|
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEiN7qqTbXXAMF_A5bxxonRa-I3fulTHkeb8KqjwwWt6UOaaor-y8YdlPFWu8WvAMxVa5ZyL5HCP3pIt9hI2OQVDdd0nC3QYsh6pma9YGfy1e1SWFwLzGx0QJheEky1STlTRPTfAnh0fhq9RfjDDefSVqpbsFeaLSF0M5G4JUJ7veg=s0-d-e1-ft) | Discover how qmIF can lead to better treatment stratification of patients with melanoma |
|
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEiN7qqTbXXAMF_A5bxxonRa-I3fulTHkeb8KqjwwWt6UOaaor-y8YdlPFWu8WvAMxVa5ZyL5HCP3pIt9hI2OQVDdd0nC3QYsh6pma9YGfy1e1SWFwLzGx0QJheEky1STlTRPTfAnh0fhq9RfjDDefSVqpbsFeaLSF0M5G4JUJ7veg=s0-d-e1-ft) | Have the opportunity to ask questions during the live broadcast. |
|
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | |
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) |
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | Speaker | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | ![head shot of Yvonne Saenger, M.D.](https://blogger.googleusercontent.com/img/proxy/AVvXsEjrSZ-VdAh-qXPK33LGNV79bIEwabLiqwnZ2wWeSpQfRUD9n0s0KMeYvRoe8m1CfJshISLQNrT-A0tQtImjoO_EuLGUGNegcMctSTHlrIuhYq7fouOJbeX1AHec0mRHtiIzrxG21668cnqlTZwBkrkm1X6nu7LF8vR0jtc1pfbEk-SUfiVyxoDM9MI=s0-d-e1-ft) | Yvonne Saenger, M.D. | Columbia University Herbert Irving Comprehensive Cancer Center New York, NY |
| ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | | ![](https://blogger.googleusercontent.com/img/proxy/AVvXsEho6JTqoHpRH3TPlqWzqbQCwF8BLgggvUjH0JaFtlCPiyoL7NTgm-WK-S1EUkXVMnT5KFpcT4QIb4YbwhBnOM2Yt4QBrawQ59MpL8r60WNTcUF-mqvGJ_DkDdRIObglsrOAeuHdUsuXGHmZRuYT7f9AbkAUL19FoqercRrrQSc=s0-d-e1-ft) | This webinar is produced by the Science/AAAS Custom Publishing Office, and sponsored by Akoya Biosciences. | ![Logo of Akoya Biosciences](https://blogger.googleusercontent.com/img/proxy/AVvXsEj9nQ7pKTtwWOp4KgsV8fCXk1EqTY39ujRaV1Du3SixkxmIM2bwp-UPbMrb2jFwH8pUKXQ2gMlwDLm_ALy4Ad5QCbZZ8ZTtAJ37yekTq2v2p8aO4idrUlleCgyyki6tqa6yLUp_TliHBBcHcjBo2iET-2UulQzDEei4obfpNVw-tKqN9_1-qWgiHjwlbOSp=s0-d-e1-ft) |
|
|
|
|